Costantini S, Giordano R, Vernillo I, Piccioni A, Zapponi G A
Ann Ist Super Sanita. 1989;25(3):457-61.
Uremic patients undergoing long-term dialysis risk accumulating tissue aluminium burdens and developing aluminium-related syndromes, such as dialysis encephalopathy and osteomalacia. A statistical retrospective study on 253 uremic subjects was carried out to verify the predictive value of serum aluminium levels on bone aluminium accumulation. Serum and bone samples collected at the same time were analyzed for aluminium content. Analyses were performed by graphite furnace atomic absorption technique. The results verified bone aluminium concentrations of less than or equal to 60 mg/kg d.w. (dry weight) in 144 patients and greater concentrations in 109 patients. The statistical discriminant analysis showed that serum levels can be predictive in aluminium bone accumulation (lower or greater than 60 mg/kg) with about a 7% margin of error. This value may be further reduced to about 2% if two threshold limits are used (53-81 micrograms/l). The specificity and sensitivity of the test were 89.6% and 83.5%, respectively.
接受长期透析的尿毒症患者有组织铝蓄积及发生铝相关综合征的风险,如透析性脑病和骨软化症。开展了一项针对253名尿毒症受试者的统计回顾性研究,以验证血清铝水平对骨铝蓄积的预测价值。同时采集的血清和骨样本进行铝含量分析。分析采用石墨炉原子吸收技术。结果证实,144例患者的骨铝浓度小于或等于60mg/kg干重,109例患者的骨铝浓度更高。统计判别分析表明,血清水平对铝骨蓄积(低于或高于60mg/kg)具有预测性,误差幅度约为7%。如果使用两个阈值范围(53-81微克/升),该值可能会进一步降至约2%。该检测的特异性和敏感性分别为89.6%和83.5%。